Globus Medical Features Latest Innovative Technologies at Scoliosis Research Society’s International Meeting on Advanced Spine Technologies
AUDUBON, Pa., July 11, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will showcase its advanced technologies at the Scoliosis Research Society’s (SRS) 25th Annual International Meeting on Advanced Spine Techniques (IMAST) being held July 11-14, 2018, in Los Angeles, California. The company will also highlight its robotics platform technology through an industry workshop at IMAST, ExcelsiusGPS® First Clinical Experiences, featuring its revolutionary robotic guidance and navigation system on July 13 from 12:00-1:00 pm led by Dr. Jeffrey A. Goldstein, Chief of Spine Service for Education and Director of the Spine Fellowship at NYU Langone Orthopedic Hospital.
“We recognize SRS as one of the world’s premier spine societies whose mission is critical to improving the lives of patients with spinal deformities,” said Andrew Iott, Senior Vice President Global Product Development. “As leaders in the musculoskeletal device industry, we are committed to supporting the research, education, and development of medical advancements in the field of spinal deformity. We are particularly proud to be a sponsor of IMAST as well as support the continued mission of SRS.”
With over 180 products launched to date, Globus Medical has one of the most comprehensive portfolios of expandable technology in the industry. With over 12 years of experience developing expandable interbody spacer systems, combined with a track record of success, Globus has developed next generation implants that provide innovative solutions to maximize lordosis and address sagittal imbalance.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at http://www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Vice President, Business Development and Investor Relations
Phone: (610) 930-1800